Thelansis

Cervical cancer is one of the most common malignancies in the female genital tract system. It is the second leading cause of cancer mortality in women aged 20 to 39 years. The prognosis of cervical cancer patients remains poor, especially in metastatic patients. Previous studies have shown that the median survival time of metastatic cervical cancer is only 8-13 months, and the 5-year survival rate is 16.5%. Due to the poor prognosis, metastatic cervical cancer has become one of the main challenges in the world. In metastatic and recurrent Cervical cancer Single-site metastasis accounted for 68.7%, and multi-organ metastases were relatively rare. In single-site metastasis, lung metastasis was the most common, accounting for 37.9% of all patients, followed by bone metastasis (16.7%), and liver metastasis (12.5%). ·        Brain metastases were uncommon, only accounted for 1.6%. In patients with multi-organ metastases, lung plus liver metastases and lung plus ...